Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Temporal course of SARS-CoV-2 antibody positivity in patients with COVID-19 following the first clinical presentation

Martin Risch, Myriam Weber, Sarah Thiel, Kirsten Grossmann, Nadia Wohlwend, Thomas Lung, Dorothea Hillmann, Michael Ritzler, Francesca Ferrara, Susanna Bigler, Konrad Egli, Thomas Bodmer, Mauro Imperiali, Yacir Salimi, Felix Fleisch, Alexia Cusini, Harald Renz, Philipp Kohler, Pietro Vernazza, Christian Kahlert, Matthias Paprotny, View ORCID ProfileLorenz Risch
doi: https://doi.org/10.1101/2020.10.17.20214445
Martin Risch
1Zentrallabor, Kantonsspital Graubünden, Loësstrasse 170, 7000 Chur, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Myriam Weber
2Liechtensteinisches Landesspital, Heiligkreuz, 9490 Vaduz, Liechtenstein
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sarah Thiel
2Liechtensteinisches Landesspital, Heiligkreuz, 9490 Vaduz, Liechtenstein
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kirsten Grossmann
3Labormedizinisches zentrum Dr. Risch, Wuhrstrasse 14, 9490 Vaduz, Liechtenstein
4Private Universität im Fürstentum Liechtenstein, Dorfstrasse, 9495 Triesen Liechtenstein
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nadia Wohlwend
3Labormedizinisches zentrum Dr. Risch, Wuhrstrasse 14, 9490 Vaduz, Liechtenstein
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Lung
3Labormedizinisches zentrum Dr. Risch, Wuhrstrasse 14, 9490 Vaduz, Liechtenstein
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dorothea Hillmann
3Labormedizinisches zentrum Dr. Risch, Wuhrstrasse 14, 9490 Vaduz, Liechtenstein
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Ritzler
3Labormedizinisches zentrum Dr. Risch, Wuhrstrasse 14, 9490 Vaduz, Liechtenstein
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francesca Ferrara
3Labormedizinisches zentrum Dr. Risch, Wuhrstrasse 14, 9490 Vaduz, Liechtenstein
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susanna Bigler
5Labormedizinisches zentrum Dr. Risch, Waldeggstrasse 37, 3097 Liebefeld, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Konrad Egli
5Labormedizinisches zentrum Dr. Risch, Waldeggstrasse 37, 3097 Liebefeld, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Bodmer
5Labormedizinisches zentrum Dr. Risch, Waldeggstrasse 37, 3097 Liebefeld, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mauro Imperiali
6Centro medicina di laboratorio Dr. Risch, Via Arbostra 2, 6963 Pregassona, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yacir Salimi
7Clm Dr Risch arc lémanique SA, Chemin de l’Esparcette 10, 1023 Crissier, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Felix Fleisch
8Division of Infectious Diseases, Cantonal Hospital Chur, Loësstrasse 170, 7000 Chur, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexia Cusini
8Division of Infectious Diseases, Cantonal Hospital Chur, Loësstrasse 170, 7000 Chur, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Harald Renz
9Institute of Laboratory Medicine and Pathobiochemistry, Molecular Diagnostics, Philipps University Marburg, University Hospital Giessen and Marburg, Baldingerstraße, 35043 Marburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philipp Kohler
10Cantonal Hospital St Gallen, Department of Infectious Diseases and Hospital Epidemiology, Rohrschacherstrasse 95 9007 St Gallen, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pietro Vernazza
10Cantonal Hospital St Gallen, Department of Infectious Diseases and Hospital Epidemiology, Rohrschacherstrasse 95 9007 St Gallen, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christian Kahlert
10Cantonal Hospital St Gallen, Department of Infectious Diseases and Hospital Epidemiology, Rohrschacherstrasse 95 9007 St Gallen, Switzerland
11Children’s Hospital of Eastern Switzerland, Department of Infectious Diseases and Hospital Epidemiology, Claudiusstrasse 6, 9006 St. Gallen, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthias Paprotny
2Liechtensteinisches Landesspital, Heiligkreuz, 9490 Vaduz, Liechtenstein
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lorenz Risch
3Labormedizinisches zentrum Dr. Risch, Wuhrstrasse 14, 9490 Vaduz, Liechtenstein
4Private Universität im Fürstentum Liechtenstein, Dorfstrasse, 9495 Triesen Liechtenstein
12Center of Laboratory Medicine, University Institute of Clinical Chemistry, University of Bern, Inselspital, 3010 Bern, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lorenz Risch
  • For correspondence: Lorenz.risch@risch.ch
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Knowledge of the sensitivities of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) antibody tests beyond 35 days after the clinical onset of COVID-19 is insufficient. We aimed to describe positivity rate of SARS-CoV-2 assays employing three different measurement principles over a prolonged period. Two hundred sixty-eight samples from 180 symptomatic patients with COVID-19 and a reverse transcription polymerase chain reaction (RT-PCR) test followed by serological investigation of SARS-CoV-2 antibodies were included.. We conducted three chemiluminescence (including electrochemiluminscence, ECLIA), four enzyme linked immunosorbent assay (ELISA), and one lateral flow immunoassay (LFIA) test formats. Positivity rates, as well as positive (PPV) and negative predictive values (NPV) were calculated for each week after the first clinical presentation for COVID-19. Furthermore, combinations of tests were assessed within an orthogonal testing approach employing two independent assays and predictive values were calculated. Heat maps were constructed to graphically illustrate operational test characteristics. During a follow-up period of more than 9 weeks, chemiluminescence assays and one ELISA IgG test showed stable positivity rates after the third week. With the exception of ECLIA, the PPVs of the other chemiluminescence assays were ≥95% for COVID-19 only after the second week. ELISA and LFIA had somewhat lower PPVs. IgM exhibited insufficient predictive characteristics. An orthogonal testing approach provided PPVs ≥95% for patients with a moderate pretest probability (e.g., symptomatic patients), even for tests with a low single test performance. After the second week, NPVs of all but IgM assays were ≥95% for patients with low to moderate pretest probability. The confirmation of negative results using an orthogonal algorithm with another assay provided lower NPVs than the single assays. When interpreting results from SARS-CoV-2 tests, the pretest probability, time of blood draw and assay characteristics must be carefully considered. An orthogonal testing approach increases the accuracy of positive, but not negative, predictions.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The research project was funded by a grant from the government of the Principality of Liechtenstein.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Cantonal ethics boards of Zurich (BASEC Req-20-00587) and Eastern Switzerland (EKOS; BASEC Nr. Req-2020-00586)

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The data that support the findings of this study are available from the corresponding author, [LR], upon reasonable request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted October 20, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Temporal course of SARS-CoV-2 antibody positivity in patients with COVID-19 following the first clinical presentation
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Temporal course of SARS-CoV-2 antibody positivity in patients with COVID-19 following the first clinical presentation
Martin Risch, Myriam Weber, Sarah Thiel, Kirsten Grossmann, Nadia Wohlwend, Thomas Lung, Dorothea Hillmann, Michael Ritzler, Francesca Ferrara, Susanna Bigler, Konrad Egli, Thomas Bodmer, Mauro Imperiali, Yacir Salimi, Felix Fleisch, Alexia Cusini, Harald Renz, Philipp Kohler, Pietro Vernazza, Christian Kahlert, Matthias Paprotny, Lorenz Risch
medRxiv 2020.10.17.20214445; doi: https://doi.org/10.1101/2020.10.17.20214445
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Temporal course of SARS-CoV-2 antibody positivity in patients with COVID-19 following the first clinical presentation
Martin Risch, Myriam Weber, Sarah Thiel, Kirsten Grossmann, Nadia Wohlwend, Thomas Lung, Dorothea Hillmann, Michael Ritzler, Francesca Ferrara, Susanna Bigler, Konrad Egli, Thomas Bodmer, Mauro Imperiali, Yacir Salimi, Felix Fleisch, Alexia Cusini, Harald Renz, Philipp Kohler, Pietro Vernazza, Christian Kahlert, Matthias Paprotny, Lorenz Risch
medRxiv 2020.10.17.20214445; doi: https://doi.org/10.1101/2020.10.17.20214445

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (62)
  • Allergy and Immunology (142)
  • Anesthesia (44)
  • Cardiovascular Medicine (408)
  • Dentistry and Oral Medicine (67)
  • Dermatology (47)
  • Emergency Medicine (141)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (171)
  • Epidemiology (4816)
  • Forensic Medicine (3)
  • Gastroenterology (177)
  • Genetic and Genomic Medicine (671)
  • Geriatric Medicine (70)
  • Health Economics (187)
  • Health Informatics (621)
  • Health Policy (314)
  • Health Systems and Quality Improvement (200)
  • Hematology (85)
  • HIV/AIDS (155)
  • Infectious Diseases (except HIV/AIDS) (5282)
  • Intensive Care and Critical Care Medicine (326)
  • Medical Education (91)
  • Medical Ethics (24)
  • Nephrology (73)
  • Neurology (677)
  • Nursing (41)
  • Nutrition (112)
  • Obstetrics and Gynecology (124)
  • Occupational and Environmental Health (203)
  • Oncology (438)
  • Ophthalmology (138)
  • Orthopedics (36)
  • Otolaryngology (88)
  • Pain Medicine (35)
  • Palliative Medicine (15)
  • Pathology (128)
  • Pediatrics (193)
  • Pharmacology and Therapeutics (129)
  • Primary Care Research (84)
  • Psychiatry and Clinical Psychology (769)
  • Public and Global Health (1800)
  • Radiology and Imaging (321)
  • Rehabilitation Medicine and Physical Therapy (138)
  • Respiratory Medicine (255)
  • Rheumatology (86)
  • Sexual and Reproductive Health (69)
  • Sports Medicine (61)
  • Surgery (100)
  • Toxicology (23)
  • Transplantation (28)
  • Urology (37)